An Autoimmune Encephalitis Case Associated with Pembrolizumab Use
Journal of the Korean Neurological Association
; : 137-140, 2022.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-926306
Biblioteca responsável:
WPRO
ABSTRACT
Immune checkpoint inhibitors may be associated with various adverse events, including encephalitis. Here, we report a case of encephalopathy associated with pembrolizumab therapy. A 60-year-old male diagnosed with cholangiocarcinoma with peritoneal seeding presented altered mentality and cognitive function after using pembrolizumab. Electroencephalogram showed mild diffuse cerebral dysfunction. Cerebrospinal fluid (CSF) study showed no evidence of infection or autoimmune disease and no paraneoplastic antibody was detected from CSF and serum. After high-dose methylprednisolone intravenous infusion, patient’s mentality was fully recovered.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Coreano
Revista:
Journal of the Korean Neurological Association
Ano de publicação:
2022
Tipo de documento:
Artigo